Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Plasmodium
Sysmex introduces automated analyzer for malaria detection
By
LabPulse.com staff writers
The company said Plasmodium falciparum from nonfalciparum species are differentiated by the analyzer. The system can also determine the life cycle staging of the parasites detected.
September 30, 2021
MicroRNA blood test identifies severe malaria in children
By
LabPulse.com staff writers
The plasma test screens for miRNAs released by human brain endothelial cells that are associated with damage to organs, such as the lungs, kidney, or brain, caused by the sequestration of red blood cells infected with Plasmodium falciparum.
January 12, 2021
Researchers validate antibody test for malaria, try similar approach for COVID-19
By
Emily Hayes
In the article, investigators shared their experience with the development and evaluation of a panel of serological markers to measure antibody responses to liver-stage parasites, or hypnozoites, which are found in people with malaria caused by Plasmodium vivax. This type of malaria is known to lie dormant, noted an international research team from the Walter and Eliza Hall Institute of Medical Research in Australia, the Pasteur Institute in France, and Ehime University in Japan.
May 17, 2020
New field test for malaria drug resistance on horizon
By
Emily Hayes
Co-lead investigator Mindy Leelawong, PhD, and colleagues reported that they have validated a point-of-care platform for a field-deployable PCR instrument, based on a study showing the test can differentiate between the wild-type form of the malaria-causing parasite Plasmodium falciparum and mutant types that are resistant to chloroquine, an older treatment for the disease.
June 12, 2019
Page 1 of 1
